These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24254488)

  • 1. Letter by Taylor et al regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study".
    Taylor RJ; Umar F; Leyva F
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):e78. PubMed ID: 24254488
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter by Alter regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study".
    Alter P
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):e77. PubMed ID: 24254487
    [No Abstract]   [Full Text] [Related]  

  • 3. Response to letters regarding article, "Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study".
    Masci PG; Schuurman R; Barison A; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):e79. PubMed ID: 24254489
    [No Abstract]   [Full Text] [Related]  

  • 4. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter by Ellims et al regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
    Ellims AH; Iles LM; Taylor AJ
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):e1. PubMed ID: 23512783
    [No Abstract]   [Full Text] [Related]  

  • 6. Myocardial inflammation on cardiovascular magnetic resonance predicts left ventricular function recovery in children with recent dilated cardiomyopathy.
    Raimondi F; Iserin F; Raisky O; Laux D; Bajolle F; Boudjemline Y; Boddaert N; Bonnet D
    Eur Heart J Cardiovasc Imaging; 2015 Jul; 16(7):756-62. PubMed ID: 25711351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced myocardial inversion time at the null point for detection of left ventricular myocardial fibrosis in patients with dilated and hypertrophic cardiomyopathy: a pilot study.
    Sueyoshi E; Sakamoto I; Uetani M
    AJR Am J Roentgenol; 2010 Apr; 194(4):W293-8. PubMed ID: 20308473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.
    Schelbert EB; Elkayam U; Cooper LT; Givertz MM; Alexis JD; Briller J; Felker GM; Chaparro S; Kealey A; Pisarcik J; Fett JD; McNamara DM;
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response to letter regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
    Dass S; Suttie JJ; Piechnik SK; Ferreira VM; Holloway CJ; Banerjee R; Mahmod M; Cochlin L; Karamitsos TD; Robson MD; Watkins H; Neubauer S
    Circ Cardiovasc Imaging; 2013 Mar; 6(2):e2. PubMed ID: 23512784
    [No Abstract]   [Full Text] [Related]  

  • 12. Contrast-enhanced cardiovascular magnetic resonance in primary and ischemic dilated cardiomyopathy.
    Calore C; Cacciavillani L; Boffa GM; Silva C; Tiso E; Marra MP; Bacchiega E; Corbetti F; Iliceto S
    J Cardiovasc Med (Hagerstown); 2007 Oct; 8(10):821-9. PubMed ID: 17885521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial scarring caused by left ventricular assist device (LVAD) insertion demonstrated by cardiovascular magnetic resonance.
    Moon JC; Sievers B; Pennell DJ; Yacoub MH; Mohiaddin RH
    J Cardiovasc Magn Reson; 2003; 5(2):361-3. PubMed ID: 12765115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.
    Nakayama M; Yamamuro M; Takashio S; Uemura T; Nakayama N; Hirakawa K; Oda S; Utsunomiya D; Kaikita K; Hokimoto S; Yamashita Y; Morita Y; Kimura K; Tamura K; Tsujita K
    Heart Vessels; 2018 Apr; 33(4):393-402. PubMed ID: 29051976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noninvasive MR characterization of structural and functional components of reperfused infarct.
    Saeed M; Martin AJ; Saloner D; Do L; Wilson M
    Acta Radiol; 2010 Dec; 51(10):1093-102. PubMed ID: 21062130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of cardiac magnetic resonance imaging in the diagnosis of left ventricular hypertrabeculation/noncompaction.
    Stöllberger C; Finsterer J
    J Cardiovasc Magn Reson; 2004; 6(4):959-60; author reply 961-2. PubMed ID: 15646899
    [No Abstract]   [Full Text] [Related]  

  • 18. Cardiac remodelling identified by cardiovascular magnetic resonance in patients with hepatitis C infection and liver disease.
    Ngu PJ; Butler M; Pham A; Roberts SK; Taylor AJ
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):629-36. PubMed ID: 26667447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.
    Chan W; Duffy SJ; White DA; Gao XM; Du XJ; Ellims AH; Dart AM; Taylor AJ
    JACC Cardiovasc Imaging; 2012 Sep; 5(9):884-93. PubMed ID: 22974800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.